ArticleCardiovascular diabetology2022

Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events.

S Meiring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.